EP3008091A1 - CD40 SIGNALLING INHIBITOR AND A FURTHER COMPOUND, WHEREIN THE FURTHER COMPOUND IS A BILE ACID, A BILE ACID DERIVATIVE, AN TGR5-RECEPTOR AGONIST, AN FXR AGONIST OR A COMBINATION THEREOF, FOR THE TREATMENT OF CHRONIC INFLAMMATION, AND THE PREVENTION OF GASTROINTESTINAL CANCER OR FIBROSIS. | Patent Bear